TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
ORIC

Oric Pharmaceuticals Inc

Healthcare · Biotechnology

13.30$ -1.3% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ORIC
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
88.6% 93.6% 95.6% 99.2% 80.5% 84.1% 83.5% 95.7% 70.2%
86.0% 91.2% 94.8% 26.2% 75.7% 26.7% 9.2% 21.7% 11.1%
86.0% 91.2% 94.8% 98.2% 79.4% 82.4% 81.7% 93.4% 68.5%
9.7% 5.4% 2.4% 0.7% 0.8% 1.3%
14.3% 237.9% 6.5% 3.1% 8.6% 11.2% 12.0% 11.3% 6.5%
8.7% 5.6% 5.7% 3.0% 5.1% 6.1% 8.0% 9.1% 5.0%
0.5% 0.2% 0.6% 1.1% 1.1% 1.2% 0.8%
3.1% 1.0% 0.2% 0.3% 0.6% 0.5% 0.4% 0.6% 0.9%
85.7% -137.9% 93.5% 96.9% 91.4% 88.8% 88.0% 88.7% 93.5%
-148.0% -140.8% -98.5% -55.7% -82.1% -133.5% -170.8% -205.3% -168.4%
4.7% 3.7% 31.8% 7.3% 12.7% 15.8% 20.2% 25.4% 21.4%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?